𝛼SK or Search

ENTITY

Immix Biopharma Inc (IMMX US)

43

Analysis

Health Care • United States

Immix Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel class of tissue-specific therapeutics in oncology and inflammation to treat inflammatory bowel disease, including ulcerative colitis and crohn's diseases. Immix Biopharma serves customers in the United States.

more

Refresh

Exchange Announcement • 01 Oct 2026 05:10

Current Report (Form 8-K | Period ending 2026-09-29)

Exchange Announcement • 29 Sep 2026 19:22

424B5 | Prospectus

Exchange Announcement • 29 Sep 2026 19:00

Current Report (Form 8-K | Period ending 2026-09-29)

Exchange Announcement • 08 Aug 2026 05:05

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 20 Jul 2026 18:05

Current Report (Form 8-K | Period ending 2026-07-20)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x